EMEA (Europe, Middle East and Africa) Polypeptide Drug Market Report 2018

February 2018 | 119 pages | ID: E9325755523EN
QYResearch

Abstracts

In this report, the EMEA Polypeptide Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Polypeptide Drug for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Polypeptide Drug market competition by top manufacturers/players, with Polypeptide Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Merck Serono
• Ferring Pharmaceuticals
• Ipsen PHarma Biotech
• Lilly
• Asahi Kasei
• AstraZeneca
• SciClone Pharmaceuticals
• Takeda
• Roche
• Sanofi

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Injection
• Nasal administration
• Lung administration
• Oral administration
• Transdermal administration

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunity Regulating Medicine (Allergy Infection and Immune)
• Digestive System Drugs (Gastrointestinal Type)
• Bone and Connective Tissue Types (Thyroid hormones Drug)
• Gynecologic or Obstetric Drug
• Tumor Drug
• Urinary System Drug
• Metabolic Drug (Insulin and Other Hypoglycemic Agents)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Polypeptide Drug Market Report 2018

1 POLYPEPTIDE DRUG OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
  1.2.1 EMEA Polypeptide Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Polypeptide Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Injection
  1.2.4 Nasal administration
  1.2.5 Lung administration
  1.2.6 Oral administration
  1.2.7 Transdermal administration
1.3 EMEA Polypeptide Drug Market by Application/End Users
  1.3.1 EMEA Polypeptide Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
  1.3.3 Digestive System Drugs (Gastrointestinal Type)
  1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
  1.3.5 Gynecologic or Obstetric Drug
  1.3.6 Tumor Drug
  1.3.7 Urinary System Drug
  1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 EMEA Polypeptide Drug Market by Region
  1.4.1 EMEA Polypeptide Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Polypeptide Drug (2013-2025)
  1.5.1 EMEA Polypeptide Drug Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Polypeptide Drug Revenue and Growth Rate (2013-2025)

2 EMEA POLYPEPTIDE DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Polypeptide Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Polypeptide Drug Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Polypeptide Drug Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Polypeptide Drug Sale Price by Players (2013-2018)
2.2 EMEA Polypeptide Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Polypeptide Drug Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Polypeptide Drug Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Polypeptide Drug Sale Price by Type (2013-2018)
2.3 EMEA Polypeptide Drug (Volume) by Application
2.4 EMEA Polypeptide Drug (Volume and Value) by Region
  2.4.1 EMEA Polypeptide Drug Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Polypeptide Drug Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Polypeptide Drug Sales Price by Region (2013-2018)

3 EUROPE POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Polypeptide Drug Sales and Value (2013-2018)
  3.1.1 Europe Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Polypeptide Drug Revenue and Growth Rate (2013-2018)
3.2 Europe Polypeptide Drug Sales and Market Share by Type
3.3 Europe Polypeptide Drug Sales and Market Share by Application
3.4 Europe Polypeptide Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Polypeptide Drug Sales Volume by Countries (2013-2018)
  3.4.2 Europe Polypeptide Drug Revenue by Countries (2013-2018)
  3.4.3 Germany Polypeptide Drug Sales and Growth Rate (2013-2018)
  3.4.4 France Polypeptide Drug Sales and Growth Rate (2013-2018)
  3.4.5 UK Polypeptide Drug Sales and Growth Rate (2013-2018)
  3.4.6 Russia Polypeptide Drug Sales and Growth Rate (2013-2018)
  3.4.7 Italy Polypeptide Drug Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Polypeptide Drug Sales and Growth Rate (2013-2018)

4 MIDDLE EAST POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Polypeptide Drug Sales and Value (2013-2018)
  4.1.1 Middle East Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Polypeptide Drug Revenue and Growth Rate (2013-2018)
4.2 Middle East Polypeptide Drug Sales and Market Share by Type
4.3 Middle East Polypeptide Drug Sales and Market Share by Application
4.4 Middle East Polypeptide Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Polypeptide Drug Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Polypeptide Drug Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Polypeptide Drug Sales and Growth Rate (2013-2018)
  4.4.4 Israel Polypeptide Drug Sales and Growth Rate (2013-2018)
  4.4.5 UAE Polypeptide Drug Sales and Growth Rate (2013-2018)
  4.4.6 Iran Polypeptide Drug Sales and Growth Rate (2013-2018)

5 AFRICA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Polypeptide Drug Sales and Value (2013-2018)
  5.1.1 Africa Polypeptide Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Polypeptide Drug Revenue and Growth Rate (2013-2018)
5.2 Africa Polypeptide Drug Sales and Market Share by Type
5.3 Africa Polypeptide Drug Sales and Market Share by Application
5.4 Africa Polypeptide Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Polypeptide Drug Sales Volume by Countries (2013-2018)
  5.4.2 Africa Polypeptide Drug Revenue by Countries (2013-2018)
  5.4.3 South Africa Polypeptide Drug Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Polypeptide Drug Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Polypeptide Drug Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Polypeptide Drug Sales and Growth Rate (2013-2018)

6 EMEA POLYPEPTIDE DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Polypeptide Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck Serono
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Polypeptide Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Ferring Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Polypeptide Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Ipsen PHarma Biotech
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Polypeptide Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Lilly
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Polypeptide Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Asahi Kasei
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Polypeptide Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Polypeptide Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 SciClone Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Polypeptide Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Takeda
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Polypeptide Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Roche
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Polypeptide Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Roche Polypeptide Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Sanofi

7 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

7.1 Polypeptide Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polypeptide Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polypeptide Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA POLYPEPTIDE DRUG MARKET FORECAST (2018-2025)

11.1 EMEA Polypeptide Drug Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Polypeptide Drug Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Polypeptide Drug Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Polypeptide Drug Price and Trend Forecast (2018-2025)
11.2 EMEA Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Polypeptide Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Polypeptide Drug Sales Forecast by Type (2018-2025)
11.7 EMEA Polypeptide Drug Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Polypeptide Drug
Figure EMEA Polypeptide Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Polypeptide Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Nasal administration Product Picture
Figure Lung administration Product Picture
Figure Oral administration Product Picture
Figure Transdermal administration Product Picture
Figure EMEA Polypeptide Drug Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Polypeptide Drug by Application in 2017
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Examples
Table Key Downstream Customer in Immunity Regulating Medicine (Allergy Infection and Immune)
Figure Digestive System Drugs (Gastrointestinal Type) Examples
Table Key Downstream Customer in Digestive System Drugs (Gastrointestinal Type)
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Examples
Table Key Downstream Customer in Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure Gynecologic or Obstetric Drug Examples
Table Key Downstream Customer in Gynecologic or Obstetric Drug
Figure Tumor Drug Examples
Table Key Downstream Customer in Tumor Drug
Figure Urinary System Drug Examples
Table Key Downstream Customer in Urinary System Drug
Figure Metabolic Drug (Insulin and Other Hypoglycemic Agents) Examples
Table Key Downstream Customer in Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure EMEA Polypeptide Drug Market Size (Million USD) by Region (2013-2025)
Figure Europe Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Polypeptide Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Polypeptide Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Polypeptide Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Polypeptide Drug Sales Volume and Growth Rate (2013-2025)
Figure EMEA Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Polypeptide Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Polypeptide Drug Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Polypeptide Drug Sales Share by Players (2013-2018)
Figure 2017 Polypeptide Drug Sales Share by Players
Figure 2017 Polypeptide Drug Sales Share by Players
Figure EMEA Polypeptide Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Polypeptide Drug Revenue (Million USD) by Players (2013-2018)
Table EMEA Polypeptide Drug Revenue Share by Players (2013-2018)
Table 2017 EMEA Polypeptide Drug Revenue Share by Players
Table 2017 EMEA Polypeptide Drug Revenue Share by Players
Table EMEA Polypeptide Drug Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Polypeptide Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Polypeptide Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Polypeptide Drug by Type (2013-2018)
Figure EMEA Polypeptide Drug Sales Market Share by Type (2013-2018)
Table EMEA Polypeptide Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Polypeptide Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Type in 2017
Table EMEA Polypeptide Drug Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Polypeptide Drug Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Polypeptide Drug Sales Share by Application (2013-2018)
Figure Sales Market Share of Polypeptide Drug by Application (2013-2018)
Figure EMEA Polypeptide Drug Sales Market Share by Application in 2017
Table EMEA Polypeptide Drug Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Polypeptide Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Polypeptide Drug by Region (2013-2018)
Figure EMEA Polypeptide Drug Sales Market Share in 2017
Table EMEA Polypeptide Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Polypeptide Drug Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Polypeptide Drug by Region (2013-2018)
Figure EMEA Polypeptide Drug Revenue Market Share Regions in 2017
Table EMEA Polypeptide Drug Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2013-2018)
Table Europe Polypeptide Drug Sales (K Pcs) by Type (2013-2018)
Table Europe Polypeptide Drug Market Share by Type (2013-2018)
Figure Europe Polypeptide Drug Market Share by Type in 2017
Table Europe Polypeptide Drug Sales (K Pcs) by Application (2013-2018)
Table Europe Polypeptide Drug Market Share by Application (2013-2018)
Figure Europe Polypeptide Drug Market Share by Application in 2017
Table Europe Polypeptide Drug Sales (K Pcs) by Countries (2013-2018)
Table Europe Polypeptide Drug Sales Market Share by Countries (2013-2018)
Figure Europe Polypeptide Drug Sales Market Share by Countries (2013-2018)
Figure Europe Polypeptide Drug Sales Market Share by Countries in 2017
Table Europe Polypeptide Drug Revenue (Million USD) by Countries (2013-2018)
Table Europe Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Polypeptide Drug Revenue Market Share by Countries in 2017
Figure Germany Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Polypeptide Drug Sales (K Pcs) by Type (2013-2018)
Table Middle East Polypeptide Drug Market Share by Type (2013-2018)
Figure Middle East Polypeptide Drug Market Share by Type (2013-2018)
Table Middle East Polypeptide Drug Sales (K Pcs) by Applications (2013-2018)
Table Middle East Polypeptide Drug Market Share by Applications (2013-2018)
Figure Middle East Polypeptide Drug Sales Market Share by Application in 2017
Table Middle East Polypeptide Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Polypeptide Drug Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Polypeptide Drug Sales Volume Market Share by Countries in 2017
Table Middle East Polypeptide Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Polypeptide Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Polypeptide Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Polypeptide Drug Sales (K Pcs) by Type (2013-2018)
Table Africa Polypeptide Drug Sales Market Share by Type (2013-2018)
Figure Africa Polypeptide Drug Sales Market Share by Type (2013-2018)
Figure Africa Polypeptide Drug Sales Market Share by Type in 2017
Table Africa Polypeptide Drug Sales (K Pcs) by Application (2013-2018)
Table Africa Polypeptide Drug Sales Market Share by Application (2013-2018)
Figure Africa Polypeptide Drug Sales Market Share by Application (2013-2018)
Table Africa Polypeptide Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Polypeptide Drug Sales Market Share by Countries (2013-2018)
Figure Africa Polypeptide Drug Sales Market Share by Countries (2013-2018)
Figure Africa Polypeptide Drug Sales Market Share by Countries in 2017
Table Africa Polypeptide Drug Revenue (Million USD) by Countries (2013-2018)
Table Africa Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Polypeptide Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Polypeptide Drug Revenue Market Share by Countries in 2017
Figure South Africa Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Table Novartis Polypeptide Drug Basic Information List
Table Novartis Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Novartis Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Merck Serono Polypeptide Drug Basic Information List
Table Merck Serono Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Serono Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Merck Serono Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Merck Serono Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Ferring Pharmaceuticals Polypeptide Drug Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Ferring Pharmaceuticals Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Ipsen PHarma Biotech Polypeptide Drug Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Ipsen PHarma Biotech Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Lilly Polypeptide Drug Basic Information List
Table Lilly Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Lilly Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Lilly Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Lilly Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Asahi Kasei Polypeptide Drug Basic Information List
Table Asahi Kasei Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Asahi Kasei Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Asahi Kasei Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca Polypeptide Drug Basic Information List
Table AstraZeneca Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure AstraZeneca Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table SciClone Pharmaceuticals Polypeptide Drug Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure SciClone Pharmaceuticals Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Takeda Polypeptide Drug Basic Information List
Table Takeda Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Takeda Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Takeda Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Takeda Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Roche Polypeptide Drug Basic Information List
Table Roche Polypeptide Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche Polypeptide Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Roche Polypeptide Drug Sales Market Share in EMEA (2013-2018)
Figure Roche Polypeptide Drug Revenue Market Share in EMEA (2013-2018)
Table Sanofi Polypeptide Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2017
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure EMEA Polypeptide Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Polypeptide Drug Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Polypeptide Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Polypeptide Drug Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Polypeptide Drug Sales Market Share Forecast by Region (2018-2025)
Table EMEA Polypeptide Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Polypeptide Drug Revenue Market Share Forecast by Region (2018-2025)
Table Europe Polypeptide Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Polypeptide Drug Sales Market Share Forecast by Countries (2018-2025)
Table Europe Polypeptide Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Polypeptide Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Polypeptide Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Polypeptide Drug Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Polypeptide Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Polypeptide Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Polypeptide Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Polypeptide Drug Sales Market Share Forecast by Countries (2018-2025)
Table Africa Polypeptide Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Polypeptide Drug Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Polypeptide Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Polypeptide Drug Sales Market Share Forecast by Type (2018-2025)
Table EMEA Polypeptide Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Polypeptide Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources